I-Sofosbuvir
索非布韦 | I-Sofosbuvir | 1190307-88-0 | Endlini |
I-SFBM | 1256490-31-9 | Endlini | |
I-SFB-8 | 874638-80-9 | Endlini | |
I-SFB-10 | 817204-32-3 | Endlini | |
I-SFBA-1 | 863329-66-2 | Endlini | |
I-SFBMA | 1334513-02-8 | Endlini |
Igama elijwayelekile: sofosbuvir (soe FOS bue vir)
Amagama Brand: Sovaldi
I-Sofosbuvir umuthi ovimbela amagciwane osetshenziselwa ukwelapha isifo sokusha kwesibindi kohlobo C esingamahlalakhona kubantu abadala kanye nezingane ezineminyaka okungenani engu-3 ubudala kanye ne-HCV RNA replication inhibitor ene-EC50 yama-92 nM.
I-Sofosbuvir kufanele inikezwe ngokuhambisana neminye imithi elwa namagciwane (imvamisa i-ribavirin ene-peginterferon alfa noma ngaphandle kwayo).I-Sofosbuvir akufanele isetshenziswe yodwa.
I-Sofosbuvir yelapha i-genotype ethile ye-hepatitis C, futhi kubantu abathile kuphela.Sebenzisa kuphela imithi oyinqunyelwe.Ungabelani ngomuthi wakho nabanye abantu.
I-Sofosbuvir kwesinye isikhathi isetshenziswa kubantu abane-HIV, noma abantu abanomdlavuza wesibindi futhi abazofakelwa isibindi.Lo muthi awuwona umuthi wokwelapha i-HIV noma i-AIDS.
Isitoreji
Impushana | -20°C | 3 iminyaka |
4°C | iminyaka engu-2 | |
Ku-solvent | -80°C | 6 izinyanga |
-20°C | Inyanga engu-1 |
Isakhiwo samakhemikhali
Isiphakamiso18Amaphrojekthi Wokuhlola Ukuvumelana Kwekhwalithi asegunyaziwe4, futhi6amaphrojekthi angaphansi kokugunyazwa.
Uhlelo lokuphatha ikhwalithi yamazwe ngamazwe oluthuthukile lwenze isisekelo esiqinile sokuthengisa.
Ukugadwa kwekhwalithi kusebenza kuwo wonke umjikelezo wempilo womkhiqizo ukuze kuqinisekiswe ikhwalithi nomphumela wokwelapha.
Ithimba Lezindaba Zokulawula Ochwepheshe lisekela izimfuno zekhwalithi ngesikhathi sokufaka isicelo nokubhaliswa.